https://www.premera.com/medicalpolicies/2.04.123.pdf#search=policy
MEDICAL POLICY - 2.04.123 Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases BCBSA Ref. Policy: 2.04.123 Effective Date: Sep. 1, ...
https://www.premera.com/medicalpolicies/5.01.588.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.588 Pharmacologic Prevention and Treatment of HIV/AIDS ... POLICY CRITERIA | CODING | RELATED INFORMATION EVIDENCE REVIEW | REFERENCES | HISTORY ∞ ...
https://www.premera.com/medicalpolicies/7.01.92.pdf#search=policy
MEDICAL POLICY - 7.01.92 Cryoablation of Tumors Located in the Kidney, Lung, Breast, Pancreas, or Bone BCBSA Ref. Policy: 7.01.92 Effective Date: Oct. 1, 2025 Last Revised: Sep. ...
https://www.premera.com/medicalpolicies/8.01.11.pdf#search=policy
MEDICAL POLICY - 8.01.11 Transcatheter Arterial Chemoembolization (TACE) to Treat Primary or Metastatic Liver Malignancies BCBSA Ref. Policy: 8.01.11 Effective Date: Nov. 1, 2025 ...
https://www.premera.com/medicalpolicies/5.01.642.pdf#search=policy
MEDICAL POLICY - 5.01.642 Gene Therapies for Rare Diseases BCBSA Ref. Policy: 5.01.49 & 5.01.52 Effective Date: Dec. 1, 2025 Last Revised: Nov. 11, 2025 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/7.01.144.pdf#search=policy
MEDICAL POLICY - 7.01.144 Patient-Specific Instrumentation (e.g., Cutting Guides) for Joint Arthroplasty BCBSA Ref. Policy: 7.01.144 Effective Date: Nov. 1, 2025 Last Revised: ...
https://www.premera.com/medicalpolicies/7.01.147.pdf#search=policy
MEDICAL POLICY - 7.01.147 Minimally Invasive Ablation Procedures for Morton and Other Peripheral Neuromas BCBSA Ref. Policy: 7.01.147 Effective Date: Sep. 1, 2025 Last Revised: ...
https://www.premera.com/medicalpolicies/1.03.04.pdf#search=policy
MEDICAL POLICY - 1.03.04 Powered Exoskeleton for Ambulation in Patients With Lower-Limb Disabilities BCBSA Ref. Policy: 1.03.04 Effective Date: Jun. 1, 2025 Last Revised: May 12, ...
https://www.premera.com/medicalpolicies/2.02.24.pdf#search=policy
MEDICAL POLICY - 2.02.24 Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting BCBSA Ref. Policy: 2.02.24 Effective Date: Sep. 1, 2025 Last ...
https://www.premera.com/medicalpolicies/2.04.514.pdf#search=policy
MEDICAL POLICY - 2.04.514 Protein Biomarkers for Diagnosis and Risk Assessment of Prostate Cancer BCBSA Ref. Policy: 2.04.33 Effective Date: Jan. 1, 2024 Last Revised: Dec, 23, ...
https://www.premera.com/medicalpolicies/2.04.515.pdf#search=policy
MEDICAL POLICY - 2.04.515 Plasma-based Proteomic Screening in the Management of Pulmonary Nodules BCBSA Ref. Policy: 2.04.142 Effective Date: Aug. 1, 2025 Last Revised: Jul. 7, ...
https://www.premera.com/medicalpolicies/5.01.572.pdf#search=policy
PHARMACY POLICY - 5.01.572 Coverage Criteria for Excluded and Non-Formulary Drugs ... POLICY CRITERIA | CODING | RELATED INFORMATION EVIDENCE REVIEW | REFERENCES | HISTORY ∞ ...
https://www.premera.com/medicalpolicies/5.01.573.pdf#search=policy
PHARMACY POLICY - 5.01.573 Pharmacotherapy of Perinatal/Infantile and Juvenile-Onset ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/7.01.574.pdf#search=policy
MEDICAL POLICY - 7.01.574 Implantable Peripheral Nerve Stimulation for the Treatment of Chronic Pain and Other Conditions BCBSA Ref. Policy 1.01.31, 7.01.29, 7.01.106 Effective ...
https://www.premera.com/medicalpolicies/7.01.85.pdf#search=policy
MEDICAL POLICY - 7.01.85 Electrical Stimulation of the Spine as an Adjunct to Spinal Fusion Procedures BCBSA Ref. Policy: 7.01.85 Effective Date: Aug. 1, 2025 Last Revised: Jul. ...
https://www.premera.com/medicalpolicies/5.01.615.pdf#search=policy
PHARMACY POLICY - 5.01.615 Pharmacologic Treatment of Chronic Non-Infectious Liver ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.618.pdf#search=policy
MEDICAL / PHARMACY POLICY - 5.01.618 Selective Estrogen Receptor Modulators and Down ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.620.pdf#search=policy
MEDICAL POLICY - 5.01.620 Vascular Endothelial Growth Factor (VEGF) Receptor Inhibitors for Ocular Disorders BCBSA Ref. Policy: 9.03.31 Effective Date: Nov. 1, 2025* Last Revised: ...
https://www.premera.com/medicalpolicies/5.01.620_2026-01-02.pdf#search=policy
MEDICAL POLICY - 5.01.620 Vascular Endothelial Growth Factor (VEGF) Receptor Inhibitors for Ocular Disorders BCBSA Ref. Policy: 9.03.31 Effective Date: Jan. 2, 2026* Last Revised: ...
https://www.premera.com/medicalpolicies/5.01.647.pdf#search=policy
POLICY - 5.01.647 Medical Necessity Criteria for Custom Open and Preferred Formularies Effective Date: Dec. 1, 2025* Last Revised: Nov. 24, 2025 Replaces: N/A *This policy has been ...